NervGen Pharma Corp. (TSXV: NGEN)
Canada
· Delayed Price · Currency is CAD 3.000
-0.130 (-4.15%)
Dec 20, 2024, 3:59 PM EST
NervGen Pharma Employees
NervGen Pharma had 7 employees as of December 31, 2019.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
210.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2019 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch + Lomb Corporation | 13,300 |
| Bausch Health Companies Inc. | 20,270 |
| WELL Health Technologies Corp. | 1,507 |
| dentalcorp Holdings Ltd. | 9,900 |
| Tilray Brands, Inc. | 2,650 |
| Curaleaf Holdings, Inc. | 5,650 |
| Sienna Senior Living Inc. | 12,263 |
| Cronos Group Inc. | 356 |
NervGen Pharma News
- 2 days ago - NervGen Announces "At-The-Market" Equity Program - Newsfile Corp
- 5 weeks ago - NervGen Pharma GAAP EPS of -$0.07 - Seeking Alpha
- 5 weeks ago - NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates - Newsfile Corp
- 6 weeks ago - NervGen Pharma to Present at the Stifel 2024 Healthcare Conference - Newsfile Corp
- 2 months ago - NervGen Pharma Provides Update on Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury - Newsfile Corp
- 3 months ago - NervGen Pharma to Present at the Unite 2 Fight Paralysis 19th Annual Science & Advocacy Symposium Focused on Spinal Cord Injury - Newsfile Corp
- 3 months ago - NervGen Pharma to Present at the 63rd International Spinal Cord Society Annual Scientific Meeting - Newsfile Corp
- 4 months ago - NervGen Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Newsfile Corp